C R Bangham

Author PubWeight™ 95.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991 10.85
2 Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A 1997 8.05
3 Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995 3.61
4 Population dynamics of immune responses to persistent viruses. Science 1996 3.49
5 Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998 3.32
6 Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol 1997 2.76
7 Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. Lancet 1997 2.50
8 HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 1999 2.45
9 Selection forces and constraints on retroviral sequence variation. Science 2001 2.17
10 Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol 1986 2.13
11 Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992 1.94
12 Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol 1985 1.92
13 Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000 1.87
14 Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 1987 1.80
15 The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000 1.73
16 Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med 1998 1.68
17 Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol 1990 1.59
18 Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 1994 1.50
19 The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol 1994 1.46
20 Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 2000 1.34
21 Do infectious diseases drive MHC diversity? Microbes Infect 2000 1.26
22 Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles. Proc Natl Acad Sci U S A 1994 1.24
23 Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol 1999 1.20
24 The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol 1997 1.19
25 Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc Biol Sci 2001 1.19
26 Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol 1995 1.15
27 High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology 1996 1.14
28 The dynamics of HTLV-I and the CTL response. Immunol Today 1999 1.14
29 High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood 2001 1.09
30 Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr 1999 1.09
31 Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci U S A 1986 1.09
32 Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis 1994 1.06
33 Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells. J Immunol 1996 0.97
34 High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 2000 0.96
35 Virus dissemination through the brain parenchyma without immunologic control. J Immunol 1997 0.94
36 Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. J Gen Virol 1986 0.92
37 Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding. J Gen Virol 1994 0.91
38 Do T cells cause HTLV-1-associated disease?: a taxing problem. Clin Exp Immunol 1994 0.90
39 Evolutionary dynamics of HTLV-I. J Mol Evol 2000 0.88
40 Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis. J Mol Evol 1996 0.87
41 Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I. J Infect Dis 1994 0.87
42 Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse. Immunology 1986 0.87
43 Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line. J Gen Virol 1989 0.87
44 The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection. J Theor Biol 2000 0.86
45 Is human T-cell lymphotropic virus type I really silent? Philos Trans R Soc Lond B Biol Sci 2000 0.86
46 Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. AIDS Res Hum Retroviruses 1992 0.86
47 Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. Vaccine 1998 0.83
48 In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes. J Virol 2001 0.83
49 Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site. Eur J Immunol 1997 0.81
50 Direct sequencing of single primer PCR products: a rapid method to achieve short chromosomal walks. Nucleic Acids Res 1993 0.81
51 Effects of high altitude on endocrine function in the Sherpas of Nepal. J Endocrinol 1978 0.81
52 HIV infection. Why the long latent period? Nature 1990 0.81
53 Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Clin Exp Immunol 2000 0.80
54 Protection against influenza virus encephalitis by adoptive lymphocyte transfer. Virology 1997 0.80
55 Fertility of Nepalese Sherpas at moderate altitudes: comparison with high-altitude data. Ann Hum Biol 1981 0.79
56 Exercise-induced asthma in Nepalese children. Clin Allergy 1981 0.78
57 Genetic polymorphisms in isolated Sherpa populations of Nepal. Am J Phys Anthropol 1980 0.77
58 Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice. Virology 1996 0.77
59 Functional conservation of HTLV-1 rex balances the immune pressure for sequence variation in the rex gene. Virology 1997 0.76
60 Virus variation, escape from cytotoxic T lymphocytes and human retroviral persistence. Semin Cell Dev Biol 1998 0.76
61 Virology. Nosing ahead in the cold war. Nature 1990 0.75
62 Ventilatory capacity in healthy Neplasese [proceedings]. J Physiol 1977 0.75
63 AIDS: the evolving story. Trends Microbiol 2000 0.75
64 The prevalence of immediate positive skin tests in Nepalese children. Clin Allergy 1981 0.75